Insulin Price Reduction Act
Latest action · Oct 30, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 29, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Insulin Price Reduction Act
This bill prohibits health insurance plan issuers and pharmacy benefits managers (PBMs) from receiving rebates or discounts for insulin from manufacturers who certify that its current insulin list price has been reduced to an amount no greater than what the list price was for the same insulin on July 1, 2006. This restriction does not apply to discounts provided to insurance plan holders at retail sale or to flat-rate fees for service paid to PBMs. Further, insurance plans are prohibited from applying a deductible to insulin that has received such price certification.
A manufacturer may certify insulin prices by submitting to the Department of Health and Human Services data about the list price of any insulin the manufacturer has produced since January 1, 2000, and by setting the current list price for an insulin product at the 2006 rate. To remain certified, a manufacturer may not increase the list price of insulin by more than the annual increase in the medical care consumer price index. A manufacturer may certify the price of an insulin product for which it did not have a list price in 2006 by reducing the list price of such insulin to the weighted average list price in 2006 of specified insulin categories.
This bill also applies to Medicare prescription drug benefits. The bill sets the rebate for insulin under Medicaid based on the average manufacturer price of insulin during the last fiscal quarter of 2019, increasing by the medical care consumer price index thereafter.
Cosponsors 54
Members who signed on, in the order they did. Signatures ran from Oct 29, 2019 to Sep 11, 2020, with 1 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-NY | Tom Reed | Original | Oct 29, 2019 |
| D-TX | Colin Z. Allred | Nov 1, 2019 | |
| R-PA | Brian K. Fitzpatrick | Nov 12, 2019 | |
| D-MI | Elissa Slotkin | Nov 12, 2019 | |
| D-TX | Sylvia R. Garcia | Nov 12, 2019 | |
| D-FL | Alcee L. Hastings | Nov 22, 2019 | |
| D-KS | Sharice Davids | Dec 19, 2019 | |
| D-UT | Ben McAdams | Feb 14, 2020 | |
| D-DC | Eleanor Holmes Norton | Feb 14, 2020 | |
| D-MI | Haley M. Stevens | Feb 14, 2020 | |
| D-CA | Josh Harder | Feb 14, 2020 | |
| D-PA | Susan Wild | Feb 14, 2020 | |
| D-NH | Ann M. Kuster | Feb 28, 2020 | |
| D-NC | David E. Price | Feb 28, 2020 | |
| D-MI | Debbie Dingell | Feb 28, 2020 |
Actions 3
Everything that happened, newest first.
- Oct 30, 2019Referred to the Subcommittee on Health.
- Oct 29, 2019Introduced in House
- Oct 29, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2199 | Insulin Price Reduction Act | Related bill | Jul 22, 2019 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 29, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.